ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

Hong Succeeds Curran As AACR President, Horwitz Is President-Elect; 5 New Directors.

March 30, 2001

DCPC Board Approves Nine Concepts, New Small Cancer Control Grants, Rerelease Of FDA For Nutrition Core Grants

January 20, 1984

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

September 27, 1985

Donald Berry To Step Down From Departmental Posts At MD Anderson

November 26, 2010

OD Contract Concepts Okayed

October 17, 1986

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988